- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05859789
EFFECT OF MEDITERRANEAN DIET ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME
Metabolic syndrome (MS) is a cluster of metabolic abnormalities that includes hypertension, central obesity, insulin resistance, type 2-diabetes and atherogenic dyslipidaemia (1). A woman's sexual health is associated with several psychological and interpersonal factors, and may be affected by aging and metabolic changes (2).
Obesity, hypertension, dyslipidemia, and type 2-diabetes which are conditions frequently present in women with metabolic syndrome are considered risk factors for atherosclerosis and endothelial dysfunction which impairs tissue oxygenation and causes subsequent functional and structural damage to the female genital tract. A decrease in pelvic blood flow secondary to atherosclerotic disease leads to fibrosis of the vaginal wall and clitoral smooth muscle, eventually resulting in vaginal dryness and dyspareunia (3).
Women with metabolic syndrome showed higher prevalence of sexual inactivity and low sexual desire, orgasm, satisfaction, and Female sexual function (FSFI) total score in respect to women without metabolic syndrome (4). There is a link between diet and sexual performance markers to get and maintain lubrication, orgasm, and frequency of sex, as food has a favourable or negative impact on sexual activity for both sexes at any age (5). The Mediterranean diet (Med Diet) is one of the most widely described and evaluated dietary patterns in scientific literature. It is based on the traditional foods that people used to eat in countries bordering the Mediterranean Sea, including France, Spain, Greece, and Italy. It is characterized by high intakes of vegetables, legumes, fruits, nuts, grains, fish, seafood, extra virgin olive oil, and a moderate intake of red wine (6). Previous studies proved that Kegel exercise raise the level of sexual satisfaction, as the pelvic floor muscle (PFM) specifically the pubococcygeus and iliococcygeus muscles are responsible for the rhythmic involuntary contractions during orgasm (7).
According to the authors' knowledge, no prior research studied the effect of Mediterranean diet on sexual function in women with metabolic syndrome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
200 patients with metabolic syndrome complaining of sexual dysfunction, aged 25-40 years, were randomized into two equal groups, the control group (A) received sessions of Kegel exercise three times per week for 12 weeks, the study group (B) received Kegel exercise combined with Mediterranean diet regimen for 12 weeks. Female sexual function index (FSFI) questionnaire was used to evaluate sexual function of each woman in both groups, while sexual quality of life-female (SQOL_F) questionnaire was used to assess quality of life (QoL) of each woman in both groups before and after treatment.
All women will be included in this study if they fulfill the following criteria:
Sexually active women diagnosed with metabolic syndrome and complaining of sexual dysfunction:
- Abdominal adiposity (waist circumference is >88 cm)
- Low serum high density lipoprotein cholesterol
- Hypertriglyceridemia (elevated triglyceride of >150 mg/dl)
- Elevated blood pressure >130/85mmHg
- Abnormal glucose homeostasis (fasting plasma glucose concentration is >110mg/dl).
- Their age will range (25- 35 ) years
- Body mass index (BMI) ≥ (25-30) kg/m2.
Women who had met one of the following criteria will be excluded from the study:
- Women has cardiovascular disease
- Psychiatric problems
- History of alcohol abuse
- Smoker women
- Taking medication
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt
- Egypt , Giza
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:All women will be included in this study if they fulfill the following criteria:
Sexually active women diagnosed with metabolic syndrome and complaining of sexual dysfunction:
- Abdominal adiposity (waist circumference is >88 cm)
- Low serum high density lipoprotein cholesterol
- Hypertriglyceridemia (elevated triglyceride of >150 mg/dl)
- Elevated blood pressure >130/85mmHg
- Abnormal glucose homeostasis (fasting plasma glucose concentration is >110mg/dl).
- Their age will range (25- 35 ) years
Body mass index (BMI) ≥ (25-30) kg/m2.
-
Exclusion Criteria:
Women who had met one of the following criteria will be excluded from the study:
- Women has cardiovascular disease
- Psychiatric problems
- History of alcohol abuse
- Smoker women
- Taking medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: control group: Kegel exercise group
will receive Kegel exercise (3 sessions /week for 12 weeks)- Each female will be asked to "Try to squeeze her pelvic floor muscles as much as possible". She was instructed that the numbers she saw at the top of screen indicated the activity of the muscle (electrical activity), in microvolt (mv).
|
|
|
Experimental: study group: Kegel exercise combined with Mediterranean diet regimen for 12 weeks.
kegel and Mediterranean diet regimen :kegel ex same as controlled group in addition toMediterranean diet.
The recommended composition of the dietary regimen was the following: carbohydrates 50-60%, proteins 15-20%, total fat o30%, saturated fat 10% and less than 300 mg of cholesterol consumed per day.
Moreover, subjects Will
|
kegel ex in addition to mediterrian diet .
The recommended composition of the dietary regimen was the following: carbohydrates 50-60%, proteins 15-20%, total fat o30%, saturated fat 10% and less than 300 mg of cholesterol consumed per day.
Moreover, subjects Will be advised to consume at least 250-300 g of fruits, 125-150 g of vegetables and 25-50 g of nuts per day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Female sexual function index (FSFI) questionnaire
Time Frame: up to 12 weeks
|
up to 12 weeks
|
|
Sexual Quality of Life Questionnaire- Female
Time Frame: up to 12 weeks
|
up to 12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/004338
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.